These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26799673)

  • 1. Toxicological and ecotoxicological risk-based prioritization of pharmaceuticals in the natural environment.
    Guo J; Sinclair CJ; Selby K; Boxall AB
    Environ Toxicol Chem; 2016 Jun; 35(6):1550-9. PubMed ID: 26799673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan.
    Aubakirova B; Beisenova R; Boxall AB
    Integr Environ Assess Manag; 2017 Sep; 13(5):832-839. PubMed ID: 28120523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Potential Ecotoxicological Effects of Pharmaceuticals in the World's Rivers.
    Bouzas-Monroy A; Wilkinson JL; Melling M; Boxall ABA
    Environ Toxicol Chem; 2022 Aug; 41(8):2008-2020. PubMed ID: 35730333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritizing pharmaceuticals based on environmental risks in the aquatic environment in China.
    Guo J; Liu S; Zhou L; Cheng B; Li Q
    J Environ Manage; 2021 Jan; 278(Pt 1):111479. PubMed ID: 33126192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hazard of pharmaceuticals for aquatic environment: Prioritization by structural approaches and prediction of ecotoxicity.
    Sangion A; Gramatica P
    Environ Int; 2016 Oct; 95():131-43. PubMed ID: 27568576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritization of pharmaceuticals for potential environmental hazard through leveraging a large-scale mammalian pharmacological dataset.
    Berninger JP; LaLone CA; Villeneuve DL; Ankley GT
    Environ Toxicol Chem; 2016 Apr; 35(4):1007-20. PubMed ID: 25772004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems.
    Arnold KE; Brown AR; Ankley GT; Sumpter JP
    Philos Trans R Soc Lond B Biol Sci; 2014 Nov; 369(1656):. PubMed ID: 25405959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of prioritization approaches to optimize environmental monitoring and testing of pharmaceuticals.
    Burns EE; Carter LJ; Snape J; Thomas-Oates J; Boxall ABA
    J Toxicol Environ Health B Crit Rev; 2018; 21(3):115-141. PubMed ID: 29714645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-based prioritization of pharmaceuticals in the natural environment in Iraq.
    Al-Khazrajy OS; Boxall AB
    Environ Sci Pollut Res Int; 2016 Aug; 23(15):15712-26. PubMed ID: 27137195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals in the environment: good practice in predicting acute ecotoxicological effects.
    Madden JC; Enoch SJ; Hewitt M; Cronin MT
    Toxicol Lett; 2009 Mar; 185(2):85-101. PubMed ID: 19118609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research.
    Caldwell DJ; Mastrocco F; Margiotta-Casaluci L; Brooks BW
    Chemosphere; 2014 Nov; 115():4-12. PubMed ID: 24636702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecotoxicological assessment of antibiotics: A call for improved consideration of microorganisms.
    Brandt KK; Amézquita A; Backhaus T; Boxall A; Coors A; Heberer T; Lawrence JR; Lazorchak J; Schönfeld J; Snape JR; Zhu YG; Topp E
    Environ Int; 2015 Dec; 85():189-205. PubMed ID: 26411644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals.
    Donnachie RL; Johnson AC; Sumpter JP
    Environ Toxicol Chem; 2016 Apr; 35(4):1021-7. PubMed ID: 26184376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Prioritisation Schemes for Human Pharmaceuticals in the Aquatic Environment.
    Letsinger S; Kay P
    Environ Sci Pollut Res Int; 2019 Feb; 26(4):3479-3491. PubMed ID: 30515684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental Risks of Pharmaceutical Mixtures in Aquatic Ecosystems: Reflections on a Decade of Research.
    Kidd KA; Backhaus T; Brodin T; Inostroza PA; McCallum ES
    Environ Toxicol Chem; 2024 Mar; 43(3):549-558. PubMed ID: 37530415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International scientists' priorities for research on pharmaceutical and personal care products in the environment.
    Rudd MA; Ankley GT; Boxall AB; Brooks BW
    Integr Environ Assess Manag; 2014 Oct; 10(4):576-87. PubMed ID: 24954797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritizing human pharmaceuticals for ecological risks in the freshwater environment of Korea.
    Ji K; Han EJ; Back S; Park J; Ryu J; Choi K
    Environ Toxicol Chem; 2016 Apr; 35(4):1028-36. PubMed ID: 26348846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Approach for Using In Vitro and In Silico Data to Identify Pharmaceuticals with Potential (Anti-)Estrogenic Activity in Aquatic Vertebrates at Environmentally Relevant Concentrations.
    Pinto CL; Bloom RA; Laurenson JP
    Environ Toxicol Chem; 2019 Oct; 38(10):2154-2168. PubMed ID: 31291026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters.
    Sanderson H; Johnson DJ; Reitsma T; Brain RA; Wilson CJ; Solomon KR
    Regul Toxicol Pharmacol; 2004 Apr; 39(2):158-83. PubMed ID: 15041147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): A review.
    Emara Y; Lehmann A; Siegert MW; Finkbeiner M
    Integr Environ Assess Manag; 2019 Jan; 15(1):6-18. PubMed ID: 30242966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.